DK0877602T3 - Fremgangsmåde til fremstilling af pulverformede lungesurfactant-præparater - Google Patents

Fremgangsmåde til fremstilling af pulverformede lungesurfactant-præparater

Info

Publication number
DK0877602T3
DK0877602T3 DK97902186T DK97902186T DK0877602T3 DK 0877602 T3 DK0877602 T3 DK 0877602T3 DK 97902186 T DK97902186 T DK 97902186T DK 97902186 T DK97902186 T DK 97902186T DK 0877602 T3 DK0877602 T3 DK 0877602T3
Authority
DK
Denmark
Prior art keywords
preparation
pulmonary surfactant
lung surfactant
surfactant preparations
powdered
Prior art date
Application number
DK97902186T
Other languages
Danish (da)
English (en)
Inventor
Klaus Eistetter
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19602332A external-priority patent/DE19602332A1/de
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Application granted granted Critical
Publication of DK0877602T3 publication Critical patent/DK0877602T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97902186T 1996-01-24 1997-01-18 Fremgangsmåde til fremstilling af pulverformede lungesurfactant-præparater DK0877602T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19602332A DE19602332A1 (de) 1996-01-24 1996-01-24 Verfahren zur Herstellung von pulverförmigen Lungensurfactant-Zubereitungen
EP96103442 1996-03-06
PCT/EP1997/000230 WO1997026863A1 (de) 1996-01-24 1997-01-18 Verfahren zur herstellung von pulverförmigen lungensurfactant-zubereitungen

Publications (1)

Publication Number Publication Date
DK0877602T3 true DK0877602T3 (da) 2002-05-06

Family

ID=26022286

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902186T DK0877602T3 (da) 1996-01-24 1997-01-18 Fremgangsmåde til fremstilling af pulverformede lungesurfactant-præparater

Country Status (15)

Country Link
US (1) US6315983B1 (pt)
EP (1) EP0877602B1 (pt)
JP (1) JP3725166B2 (pt)
KR (1) KR100449789B1 (pt)
AT (1) ATE212220T1 (pt)
CA (1) CA2244767C (pt)
CY (1) CY2366B1 (pt)
CZ (1) CZ292186B6 (pt)
DE (1) DE59706180D1 (pt)
DK (1) DK0877602T3 (pt)
ES (1) ES2171883T3 (pt)
PT (1) PT877602E (pt)
TR (1) TR199801408T2 (pt)
UA (1) UA59358C2 (pt)
WO (1) WO1997026863A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203036A1 (en) * 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
WO1998029096A1 (en) * 1996-12-31 1998-07-09 Inhale Therapeutic Systems Aerosolized hydrophobic drug
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
EP1767195A3 (en) * 1998-08-25 2007-04-04 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
EP1107743B1 (en) * 1998-08-25 2007-06-27 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
AU1161300A (en) * 1998-11-10 2000-05-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Treatment set containing lungsurfactant compositions
CA2372558A1 (en) * 1999-06-11 2000-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
US6749835B1 (en) * 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
ATE285755T1 (de) * 1999-08-25 2005-01-15 Advanced Inhalation Res Inc Grosse poröse partikel erhältlich durch sprühtrocknung und geeignet zur pulmonalen anwendung
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
EP1216052A1 (en) 1999-09-16 2002-06-26 Byk Gulden Lomberg Chemische Fabrik GmbH Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
WO2003033014A2 (de) 2001-10-11 2003-04-24 Altana Pharma Ag Neue verwendung von lungensurfactant
WO2003043603A1 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
US20030170223A1 (en) * 2002-02-01 2003-09-11 Board Of Trustees Of Michigan State University Pulmonary vasodilator surfactant compositions and method of use
CN1642533A (zh) * 2002-03-18 2005-07-20 山之内制药株式会社 吸入用粉末医药组合物及其制备方法
US20040184995A1 (en) * 2003-03-17 2004-09-23 Yamanouchi Pharmaceutical Co., Ltd. Novel dry powder inhalation for lung-delivery and manufacturing method thereof
AU2005247410A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
ES2339954T3 (es) * 2004-08-06 2010-05-27 Nycomed Gmbh Composicion que comprende un agente tensioactivo pulmonar y un peptido derivado de tnf.
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
EP1830810A4 (en) * 2004-12-30 2011-02-02 Dobeel Co Ltd SPRAY-DRYED COMPOSITION WITH PROTEINS OF THE COLLECTIN FAMILY OR VARIATIONS THEREOF AND METHOD OF PREPARATION THEREOF
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
EP2009023A1 (en) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
CA2718902C (en) 2008-03-17 2014-05-06 Discovery Laboratories, Inc. Ventilation circuit adaptor and proximal aerosol delivery system
EP2626098B1 (en) 2008-10-22 2020-08-19 Trudell Medical International Modular aerosol delivery system
CA2744940A1 (en) 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
CN102497853B (zh) * 2009-03-26 2018-03-23 普马特里克斯营业公司 治疗肺病的干粉配方与方法
EP2711004A1 (en) * 2009-10-05 2014-03-26 Nutri-Fit GmbH & Co. KG Methods for increasing physical capacity of mammalian livestock
KR101957530B1 (ko) 2010-08-23 2019-03-12 프라운호퍼-게젤샤프트 추르 푀르데룽 데어 안제반텐 포르슝 에 파우 치료학적 활성 물질을 포함하는 가습 입자
BR112014024057A8 (pt) 2012-03-28 2018-01-16 Discovery Lab Inc processo para fabricar um tensoativo pulmonar sintético liofilizado, composição de tensoativo pulmonar sintético liofilizado, e, tensoativo pulmonar sintético liofilizado
AU2015226289B8 (en) 2014-03-05 2019-10-31 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for providing a constant amount of aerosol
CN106163600B (zh) 2014-03-05 2019-03-22 弗劳恩霍夫应用研究促进协会 用于对气溶胶进行加湿的加湿器
JP6397984B2 (ja) * 2014-03-18 2018-09-26 アペプティコ・フォルシュング・ウント・エントヴィックルング・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＡｐｅｐｔｉｃｏ Ｆｏｒｓｃｈｕｎｇ Ｕｎｄ Ｅｎｔｗｉｃｋｌｕｎｇ Ｇｍｂｈ 乾燥粉末ペプチド医薬
EP3474832A1 (en) * 2016-06-24 2019-05-01 Civitas Therapeutics, Inc. Surfactant formulations for inhalation
MX2020006634A (es) 2017-12-21 2021-01-15 Civitas Therapeutics Inc Formulaciones de surfactantes para inhalacion.
MX2020006633A (es) * 2017-12-21 2021-01-15 Civitas Therapeutics Inc Formulaciones de surfactantes para inhalacion.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58183621A (ja) * 1982-04-22 1983-10-26 Teijin Ltd 肺表面活性物質を有効成分とする粉末剤の調製法
DE3229179C2 (de) 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
JPS59164724A (ja) 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
EP0482097B1 (en) 1989-07-11 2001-06-06 Genentech, Inc. Surfactant compositions and methods
IN172208B (pt) * 1990-04-02 1993-05-01 Sint Sa
WO1992006703A1 (en) 1990-10-17 1992-04-30 The Liposome Company, Inc. Synthetic lung surfactant
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
EP0655237A1 (de) * 1993-11-27 1995-05-31 Hoechst Aktiengesellschaft Medizinische Aerosolformulierung
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
PT748213E (pt) 1994-03-07 2004-08-31 Nektar Therapeutics Metodos e composicoes para administracao pulmonar de insulina
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US6019968A (en) 1995-04-14 2000-02-01 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
JP3708553B2 (ja) * 1995-04-14 2005-10-19 ネクター セラピューティクス 向上した分散性を有する粉末型薬理組成物
WO1998029096A1 (en) * 1996-12-31 1998-07-09 Inhale Therapeutic Systems Aerosolized hydrophobic drug
GB9814172D0 (en) 1998-06-30 1998-08-26 Andaris Ltd Formulation for inhalation
EP1107743B1 (en) 1998-08-25 2007-06-27 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations

Also Published As

Publication number Publication date
ATE212220T1 (de) 2002-02-15
CA2244767C (en) 2005-11-22
DE59706180D1 (de) 2002-03-14
TR199801408T2 (xx) 1998-10-21
KR19990081886A (ko) 1999-11-15
JP3725166B2 (ja) 2005-12-07
US6315983B1 (en) 2001-11-13
ES2171883T3 (es) 2002-09-16
KR100449789B1 (ko) 2005-02-03
UA59358C2 (uk) 2003-09-15
CA2244767A1 (en) 1997-07-31
CZ292186B6 (cs) 2003-08-13
EP0877602B1 (de) 2002-01-23
WO1997026863A1 (de) 1997-07-31
CY2366B1 (en) 2004-06-04
CZ233898A3 (cs) 1999-02-17
JP2000503976A (ja) 2000-04-04
EP0877602A1 (de) 1998-11-18
PT877602E (pt) 2002-07-31

Similar Documents

Publication Publication Date Title
DK0877602T3 (da) Fremgangsmåde til fremstilling af pulverformede lungesurfactant-præparater
CY1107488T1 (el) Σταθερα ξηραμενα δια ψεκασμου πρωτεϊνικα σκευασματα
DE69632669T2 (de) Salz-stabilisierte Enzymzubereitung
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
DK164870C (da) Fremgangsmaade til fremstilling af acarbose med et acarbose-indhold paa mindst 90 vaegtprocent paa toerstofbasis, eller en vandig oploesning deraf
PT758248E (pt) Formulacoes para o factor ix
EP0336760A3 (en) Bone-inducing protein
NO863061L (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
NO865079L (no) Fremgangsmaate for fremstilling av stabiliserte humanvevplasminogenaktivatorpreparater.
ATE230612T1 (de) Stabile pulverförmige vitamin- und carotinoid- zubereitungen und vefahren zu deren herstellung
JPS54147916A (en) Preparation of urokinase injection
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
DK1212039T3 (da) Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel
EA199800649A1 (ru) Способ получения порошковых препаратов лёгочного поверхностно-активного вещества
NO883356D0 (no) Fremgangsmaate til fremstilling av et aromatkonsentrat til bruk som tilsetning til et forgasserdrivstoff.
MY101266A (en) Pharmaceutical formulations
BG104452A (en) New derivatives of the methylenebisphosphonic acid
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation
JPS52108088A (en) Preparation of monohydroxycarboxylic acid using microbials
JPS5696693A (en) Production of human standard enzyme sample from human placenta
NO873452L (no) Fremgangsmaate for fremstilling av galeniske preparater.
KR870010793A (ko) 수혈과 인삼엑기스를 이용한 삼혈분말의 제조방법
DE59812309D1 (de) Teppichreinigungspulver mit einer aktivsauerstoffquelle
MX9700484A (es) Leche sin lactosa y leche en polvo sin lactosa, y alimentos que los contienen y proceso para fabricarlos.
JPS52151148A (en) Preparation of substituted cyclopropanecarboxylic acid derivatives